Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK GUNVOR JØRNSGÅRD D.C. ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   1.6% 1.4% 1.2% 1.7% 1.6% 1.5% 17.9% 16.2%   Credit score (0-100)   76 80 81 72 74 75 8 11   Credit rating   A A A A A A B BB   Credit limit (kDKK)   4.8 27.8 58.4 3.3 4.7 8.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,098 4,096 4,103 4,127 3,933 4,169 0.0 0.0   EBITDA   694 725 715 540 562 617 0.0 0.0   EBIT   571 654 652 446 487 547 0.0 0.0   Pre-tax profit (PTP)   473.5 629.3 636.1 491.4 541.9 569.7 0.0 0.0   Net earnings   368.7 490.3 496.1 382.9 419.5 444.2 0.0 0.0   Pre-tax profit without non-rec. items   473 629 636 491 542 570 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   79.5 16.0 229 178 127 76.5 0.0 0.0   Shareholders equity total   975 1,266 1,262 1,145 1,064 1,008 308 308   Interest-bearing liabilities   1,053 202 47.9 183 79.4 0.0 0.0 0.0   Balance sheet total (assets)   2,711 2,102 2,201 1,891 1,604 1,575 308 308   Net Debt   -1,045 -1,333 -1,344 -1,008 -905 -997 -308 -308     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,098 4,096 4,103 4,127 3,933 4,169 0.0 0.0   Gross profit growth   10.3% -0.0% 0.2% 0.6% -4.7% 6.0% -100.0% 0.0%   Employees   8 9 8 8 7 7 0 0   Employee growth %   14.3% 12.5% -11.1% 0.0% -12.5% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,711 2,102 2,201 1,891 1,604 1,575 308 308   Balance sheet change%   7.5% -22.5% 4.7% -14.1% -15.2% -1.8% -80.4% 0.0%   Added value   693.9 725.2 715.3 540.2 581.2 616.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -216 -135 150 -145 -126 -121 -76 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.9% 16.0% 15.9% 10.8% 12.4% 13.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.1% 27.4% 30.3% 24.8% 31.8% 36.0% 0.0% 0.0%   ROI %   31.5% 37.3% 44.5% 36.8% 45.0% 53.1% 0.0% 0.0%   ROE %   28.6% 43.8% 39.3% 31.8% 38.0% 42.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   36.0% 60.2% 57.3% 60.5% 66.3% 64.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -150.6% -183.8% -187.9% -186.6% -160.9% -161.7% 0.0% 0.0%   Gearing %   108.0% 16.0% 3.8% 16.0% 7.5% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.2% 4.6% 12.8% 14.6% 10.4% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 2.3 2.2 2.0 2.4 2.3 0.0 0.0   Current Ratio   1.4 2.3 2.2 2.0 2.4 2.3 0.0 0.0   Cash and cash equivalent   2,097.8 1,534.9 1,392.3 1,190.6 984.0 996.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   554.6 934.7 814.4 563.8 465.8 441.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   87 81 89 68 83 88 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   87 81 89 68 80 88 0 0   EBIT / employee   71 73 82 56 70 78 0 0   Net earnings / employee   46 54 62 48 60 63 0 0